Industry

I read with great interest the blog “Avastin W” by John A. Hovanesian, whom I would like to congratulate for touching on a delicate argument that affects the quality of life of individuals affected by macular and retinal diseases.

A company specializing in therapeutics for rare and neurodegenerative diseases has announced a partnership with a provider of innovative solutions in early-stage drug discovery to develop a BRD9 inhibitor to treat Huntington’s disease.

SAN FRANCISCO — Ophthalmologists need to work with industry to reduce the carbon footprint created by medical products, according to a speaker at the American Academy of Ophthalmology meeting.

Researchers identified an association between industry payments to physicians and nonrecommended and low-value drugs in certain clinical scenarios, according to study results published in The BMJ.

NEW ORLEANS — Alcon introduced its recently launched Total30 Multifocal contact lens, a reusable, monthly lens for patients with presbyopia that features the company’s water gradient technology, at Academy ’23.

The New England College of Optometry recently hosted its third annual Industry Collaborative, welcoming more than 120 guests from the eye care industry, health care, academia and media to discuss supply and demand in optometry.

A new report from Transitions Optical spotlighted five emerging trends in the optical industry, collected with input from a group of eye care professionals and opinion leaders.

Physicians who receive industry payments are more likely to administer hyaluronic acid injections, as well as an increased volume of injections, for osteoarthritis despite questionable benefit, according to data.

It has been a joy to see the COVID pandemic coming to a close, with many of my colleagues and I going back to live meetings, sharing pearls, and making our personal and eye care practices flourish again.

Ophthalmology is an exciting field that is constantly growing and evolving.